J Uriach Y Compania, S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 17, 2014
Pages: 43
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I8AC9B747AFEN
Leaflet:

Download PDF Leaflet

J Uriach Y Compania, S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

J Uriach Y Compania, S.A. (Grupo Uriach) is a pharmaceutical company, which develops and markets prescription drugs and OTC products. It carries out business in three divisions, namely, Uriach Pharma, Uriach Aquilea OTC, and Industrial Area. The company through its Uriach Pharma business division markets prescription pharmaceutical specialties for various therapeutic areas such as antiplatelet drugs, anti-hypertensive agents, anti-histaminics, antibiotics, anti-mycotics and anti-anemics. Its Uriach Aquilea OTC division carries out the marketing of OTC products. Its OTC product portfolio includes medicinal plants and food complements in the therapeutic areas of gynaecology, urology and weight control products. The company through its Industrial Area division offers various contract development and contract manufacturing services. It operates in more than 150 countries across five continents. Uriach is headquartered at Barcelona, Spain.

J Uriach Y Compania, S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
J Uriach Y Compania, S.A., Medical Devices Deals, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million
Partnerships
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine
Breckenridge Pharma Enters Into Co-Marketing Agreement With Oman Pharma Products
Breckenridge Pharma Enters Into Co-Marketing Agreement With Tris Pharma
Breckenridge Pharma Enters Into Co-Marketing Agreement With Genepharm
Breckenridge Pharma Enters Into Agreement With Orit Labs
Laboratorios Del Dr. Esteve Signs Partnership Agreement With irsiCaixa Foundation
Breckenridge Enters Into Co-Development Agreement With Helm
Breckenridge Enters Into Co-Development Agreement With IDL
Breckenridge Enters Into Co-Marketing Agreement With Orit Labs
Breckenridge Pharma Enters Into An Agreement With Helm
Licensing Agreements
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine
ReGenX Biosciences Enters Into Licensing Agreement With Esteve
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug
Recordati Enters Into Licensing Agreement With Laboratorios Del Dr. Esteve
GlaxoSmithKline Enters Into Licensing Agreement With Grupo Uriach For Rupatadine
Acquisition
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach
Pensa Pharma Acquires Breckenridge Pharma, Generic Drugs Company
Esteve Acquires Breckenridge Pharma
Esteve Teijin Healthcare Acquires 51% Stake In Oximeplus From Laboratorios Del Dr. Esteve
J Uriach Y Compania, S.A. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Key Facts
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
J Uriach Y Compania, S.A., Deals By Therapy Area, 2008 to YTD 2014
J Uriach Y Compania, S.A., Medical Devices Deals, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine
Breckenridge Pharma Enters Into Co-Marketing Agreement With Oman Pharma Products
Breckenridge Pharma Enters Into Co-Marketing Agreement With Tris Pharma
Breckenridge Pharma Enters Into Co-Marketing Agreement With Genepharm
Breckenridge Pharma Enters Into Agreement With Orit Labs
Laboratorios Del Dr. Esteve Signs Partnership Agreement With irsiCaixa Foundation
Breckenridge Enters Into Co-Development Agreement With Helm
Breckenridge Enters Into Co-Development Agreement With IDL
Breckenridge Enters Into Co-Marketing Agreement With Orit Labs
Breckenridge Pharma Enters Into An Agreement With Helm
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine
ReGenX Biosciences Enters Into Licensing Agreement With Esteve
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug
Recordati Enters Into Licensing Agreement With Laboratorios Del Dr. Esteve
GlaxoSmithKline Enters Into Licensing Agreement With Grupo Uriach For Rupatadine
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach
Pensa Pharma Acquires Breckenridge Pharma, Generic Drugs Company
Esteve Acquires Breckenridge Pharma
Esteve Teijin Healthcare Acquires 51% Stake In Oximeplus From Laboratorios Del Dr. Esteve
J Uriach Y Compania, S.A., Key Competitors
J Uriach Y Compania, S.A., Key Employees
J Uriach Y Compania, S.A., Other Locations
J Uriach Y Compania, S.A., Subsidiaries

LIST OF FIGURES

J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
J Uriach Y Compania, S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
J Uriach Y Compania, S.A., Medical Devices Deals, 2008 to YTD 2014

Ask Your Question

J Uriach Y Compania, S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: